NOC from BSE for reclassification of Akshath Finvest and Properties Private Limited from Promoter Group Category to Public Category
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has received a No-Objection letter from BSE for reclassifying Akshath Finvest and Properties Private Limited from the 'Promoter Group' category to the 'Public' category under SEBI LODR Regulation 31A. Akshath Finvest held 4,94,182 equity shares, representing 5.12% of the company's shareholding. The reclassification was originally applied for on May 30, 2025, and has now been approved by the exchange on September 26, 2025. This is purely a regulatory category change and does not involve any actual transfer of shares or change in beneficial ownership.
The promoter group's effective shareholding in Sandu Pharmaceuticals reduces by 5.12% on a classification basis, potentially giving the public category a higher share of voting influence on paper. There is no immediate effect on stock price since no shares are being bought or sold.